Valuation : Viyash Scientific Limited

Market Cap 11TCr 119.74Cr 103.3Cr 97Cr 89Cr 165.72Cr 166.96Cr 1.15TCr 447.1Cr 5.78TCr 449.62Cr 439.79Cr 19TCr P/E 2027 *
37x
P/E 2028 * 22.3x
Enterprise Value 11TCr 119.74Cr 103.3Cr 97Cr 89Cr 165.72Cr 166.96Cr 1.15TCr 447.1Cr 5.78TCr 449.62Cr 439.79Cr 19TCr EV / Sales 2027 *
2.9x
EV / Sales 2028 * 2.53x
Free-Float
32.71%
Yield 2027 *
-
Yield 2028 * -
1 day-1.14%
1 week-6.85%
Current month-1.74%
1 month+2.82%
3 months+3.45%
6 months+21.87%
Current year+24.50%
1 week 256.5
Extreme 256.5
271
1 month 245.3
Extreme 245.3
281.15
Current year 178.4
Extreme 178.4
297.9
1 year 169.3
Extreme 169.3
297.9
3 years 86.03
Extreme 86.03
297.9
5 years 61.8
Extreme 61.8
297.9
10 years 42.45
Extreme 42.45
336.4
Manager TitleAgeSince
Chief Executive Officer 62 16/12/2025
Director of Finance/CFO - 01/01/2026
Chief Tech/Sci/R&D Officer - 05/02/2026
Director TitleAgeSince
Chairman 78 -
Director/Board Member 67 25/08/2020
Director/Board Member 57 11/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%-6.85%+52.17%+179.77% 120.56Cr
+0.01%-5.96%+58.36%+108.23% 1,03400Cr
+1.48%+0.76%+55.34%+71.49% 65TCr
+0.67%-1.53%+24.39%+76.60% 46TCr
+0.49%-6.58%+34.20%+34.59% 34TCr
+0.27%+2.32%+29.33%+46.97% 31TCr
+0.12%-4.01%+1.06%+11.93% 25TCr
+1.08%+0.14%+53.92%+72.51% 24TCr
+2.64%-2.00%-17.38%-53.64% 20TCr
-0.21%+0.56%+32.43%+95.19% 19TCr
Average +0.54%-3.17%+32.38%+64.36% 36.73TCr
Weighted average by Cap. +0.63%-3.31%+39.22%+67.35%

Financials

2027 *2028 *
Net sales 3.9TCr 41Cr 36Cr 34Cr 31Cr 57Cr 58Cr 397.16Cr 154.13Cr 1.99TCr 155.01Cr 151.62Cr 6.55TCr 4.47TCr 47Cr 41Cr 38Cr 35Cr 65Cr 66Cr 455.11Cr 176.63Cr 2.28TCr 177.62Cr 173.74Cr 7.5TCr
Net income 343.83Cr 3.64Cr 3.14Cr 2.96Cr 2.7Cr 5.04Cr 5.08Cr 35Cr 14Cr 175.79Cr 14Cr 13Cr 577.47Cr 539.52Cr 5.71Cr 4.93Cr 4.64Cr 4.23Cr 7.9Cr 7.96Cr 55Cr 21Cr 275.84Cr 21Cr 21Cr 906.13Cr
Net Debt - -
Logo Viyash Scientific Limited
Viyash Scientific Limited, formerly SeQuent Scientific Limited, is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. The Company has eight manufacturing facilities, based in India, Turkey, Brazil, Spain and Germany. It is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It specializes in analytical and bioanalytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It offers analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer-developed methods or in-house method development.
Employees
2,900
Date Price Change Volume
02/26/02 ₹259.15 -1.14% 94,809
01/26/01 ₹262.15 -0.61% 2,74,047
31/26/31 ₹263.75 -1.31% 1,64,080
28/26/28 ₹267.25 +2.79% 3,05,819
27/26/27 ₹260.00 -1.23% 8,36,375
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
259.15INR
Average target price
322.25INR
Spread / Average Target
+24.35%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIYASH Stock